Source link : https://newshealth.biz/health-news/glp-1-less-frequent-dosing-may-maintain-weight-loss/
TOPLINE: Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) administered at off-label reduced dosing maintained weight-loss benefits, with patients retaining the effects even with 2-4 weeks between doses. METHODOLOGY: GLP-1 RAs are transforming obesity treatment, but high costs and shortages limit patient access. Clinicians have suggested a less frequent dosing to maintain weight loss, but evidence […]
The post GLP-1 Less Frequent Dosing May Maintain Weight Loss first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-03 11:16:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8